1 – 30 of 30
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Proteomic profiling of extracellular vesicles reveals additional diagnostic biomarkers for myocardial infarction compared to plasma alone
(
- Contribution to journal › Article
- 2017
-
Mark
Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
(
- Contribution to journal › Article
- 2016
-
Mark
Comparative Proteomic Analysis of Extracellular Vesicles Isolated by Acoustic Trapping or Differential Centrifugation
(
- Contribution to journal › Article
- 2015
-
Mark
A protein deep sequencing evaluation of metastatic melanoma tissues.
(
- Contribution to journal › Article
- 2014
-
Mark
Inflammatory Markers in Huntington’s Disease Plasma – A Robust NanoLC-MRM-MS Assay Development
(
- Contribution to journal › Article
-
Mark
A New Look at Drugs Targeting Malignant Melanoma – An Application for Mass Spectrometry Imaging
(
- Contribution to journal › Scientific review
-
Mark
Aptamer/ISET-MS: A New Affinity-Based MALDI Technique for Improved Detection of Biomarkers
(
- Contribution to journal › Article
- 2013
-
Mark
Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability
(
- Contribution to journal › Article
-
Mark
Chromosome 19 Annotations with Disease Speciation - A First Report from the Global Research Consortium
(
- Contribution to journal › Article
-
Mark
Developments in Biobanking Workflow Standardization Providing Samples Integrity and Stability
(
- Contribution to journal › Scientific review
-
Mark
Experimental Models to Study Drug Distributions in Tissue Using MALDI Mass Spectrometry
(
- Contribution to journal › Article
-
Mark
Identification of a Novel Proteoform of Prostate Specific Antigen (SNP-L132I) in Clinical Samples by Multiple Reaction Monitoring.
(
- Contribution to journal › Article
-
Mark
A Critical Evaluation of Inflammatory Markers in Huntington’s Disease Plasma
(
- Contribution to journal › Article
- 2012
-
Mark
Standardization and Utilization of Biobank Resources in Clinical Protein Sciene with Examples of Emerging Applications
(
- Contribution to journal › Article
-
Mark
Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry.
(
- Contribution to journal › Article
- 2011
-
Mark
Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples
(
- Contribution to journal › Article
-
Mark
MRM assay for quantitation of complement components in human blood plasma - a feasibility study on multiple sclerosis.
(
- Contribution to journal › Article
-
Mark
Drug Localization in Different Lung Cancer Phenotypes by MALDI Mass Spectrometry Imaging
(
- Contribution to journal › Article
-
Mark
Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels
(
- Contribution to journal › Article
- 2010
-
Mark
Identification of prostate specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms
(
- Contribution to journal › Article
-
Mark
Isotope labeled internal standards (ILIS) as a basis for quality control in clinical studies using plasma samples
(
- Contribution to journal › Article
-
Mark
Mass spectrometric strategy for clearcut identification of prostate specific antigen in clinical Samples
2010) 4th EuPA Scientific Meeting - A Proteomics Odyssey Towards Next Decades In [Publication information missing] p.114-117(
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of PSA in clinical samples by mass spectrometry
2010) 4th EuPA Scientific Meeting - A Proteomics Odyssey Towards Next Decades In [Publication information missing] p.508-510(
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of PSA in clinical samples by mass spectrometry
2010) Swedish Proteomics Society Symposium, 2010(
- Contribution to conference › Abstract
-
Mark
MRM assay for quantification of complement components in human blood plasma
2010) Swedish Proteomics Society Symposium, 2010(
- Contribution to conference › Abstract
-
Mark
MRM assay for quantification of complement components in human blood plasma
2010) 4th EuPA Scientific Meeting - A Proteomics Odyssey Towards Next Decades In [Publication information missing] p.435-437(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Isotope labeled internal standards (ILIS) as the basis for QC-Control in human plasma analysis
(
- Contribution to journal › Published meeting abstract
-
Mark
Multiplex approach for identification of PSA variants in clinical samples
(
- Contribution to journal › Published meeting abstract
-
Mark
An analytical platform for clinical blood sample studies
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Stability study on human plasma – controlling clinical sample quality
2008) Swedish Proteomics Society Symposium, 2008(
- Contribution to conference › Abstract